NeoGenomics to Report Third Quarter 2026 Financial Results on October 28, 2026
Business Wire•14/10/2026•07:05 ET
0
Key Highlights
- ➤NeoGenomics will report third-quarter 2026 results after U.S. market close October 28, 2026
- ➤Management will host a webcast and conference call at 4:30 p.m. ET
- ➤NeoGenomics provides oncology diagnostics and cancer genetics testing services
NeoGenomics to Report Third Quarter 2026 Financial Results on October 28, 2026
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its third quarter 2026 financial results after the close of the U.S. financial markets on Wednesday, October 28, 2026. Company management will host a webcast and conference call at 4:30 p.m. ET to discuss financial results and recent highlights.
Get started
Create a free account to read the full story.